News & Updates

Colchicine: A potential outpatient treatment for PCR-confirmed COVID-19?

02 Sep 2021 by

The use of the anti-inflammatory drug colchicine in an outpatient setting may reduce the risk of COVID-19–related death or hospitalization in patients with PCR-confirmed COVID-19, according to results of the phase III COLCORONA* trial.

Colchicine: A potential outpatient treatment for PCR-confirmed COVID-19?

02 Sep 2021

Omalizumab stops proliferation, transformation of fibrocytes in severe allergic asthma

02 Sep 2021

The anti-immunoglobulin (Ig) E therapy omalizumab lessens the number of circulating fibrocytes, cell and number of fibrocytes, and α-smooth muscle actin (α-SMA)+ fibrocytes after 3–7 days of culture in patients with severe allergic asthma (SAA), a study has shown.

Omalizumab stops proliferation, transformation of fibrocytes in severe allergic asthma

02 Sep 2021

Delta and beyond: Is a third COVID-19 vaccine jab the answer?

31 Aug 2021 by

More than 8 months since the first COVID-19 vaccine is made available to the masses, the world has held the hope of a return to normalcy just to see it dashed again with the recent surge in COVID-19 cases.

Delta and beyond: Is a third COVID-19 vaccine jab the answer?

31 Aug 2021

Zolpidem plus atomoxetine-oxybutynin improves sleep efficiency in OSA patients

31 Aug 2021

The addition of zolpidem to the combination of atomoxetine and oxybutynin (Ato-Oxy) increases the respiratory arousal threshold to counteract potential wake-promoting properties of atomoxetine in obstructive sleep apnoea (OSA), resulting in improved sleep efficiency, according to a study.

Zolpidem plus atomoxetine-oxybutynin improves sleep efficiency in OSA patients

31 Aug 2021

Airborne threat: Surgical masks may be the answer, but not cloth masks or face shields

30 Aug 2021 by

Wearing a surgical face mask provides a high protective effect against aerosols while posing low airflow resistance, in contrast to plastic face shields which offer little to no protection, a study reveals.

Airborne threat: Surgical masks may be the answer, but not cloth masks or face shields

30 Aug 2021

Studies highlight potential link between COVID-19 and cognitive impairment

27 Aug 2021 by

Several studies presented at AAIC 2021 have suggested a possible link between COVID-19 and cognitive impairment.

Studies highlight potential link between COVID-19 and cognitive impairment

27 Aug 2021

Keeping windows open best for preventing COVID-19 spread in cars

27 Aug 2021 by

Keeping car windows open and wearing face mask can help protect passengers from the risk of contracting COVID-19, even though this may expose them to outdoor air pollution, a study finds.

Keeping windows open best for preventing COVID-19 spread in cars

27 Aug 2021

Leg, trunk mass decline in COPD patients

27 Aug 2021 by

Fat-free mass (FFM) significantly decreases among patients with chronic obstructive pulmonary disease (COPD) after 2 years of follow-up, a recent study has found. Such decline is more noticeable in the legs and trunk.

Leg, trunk mass decline in COPD patients

27 Aug 2021

COVID-19 days fewer in children; experts explain why

25 Aug 2021 by

Most symptomatic children who tested positive for SARS-CoV-2 recovered within a week, and only a small subset of children experienced lingering symptoms in the COVID Symptom Study, one of the largest UK citizen participatory epidemiological studies thus far.

COVID-19 days fewer in children; experts explain why

25 Aug 2021

Adding azithromycin to standard care yields no survival benefit in ambulatory managed COVID-19

24 Aug 2021 by

The addition of azithromycin to standard care did not reduce hospitalization or mortality risk in patients with mild-to-moderate COVID-19 who underwent ambulatory management, according to results of the ATOMIC2 trial presented at ECCMID 2021.

Adding azithromycin to standard care yields no survival benefit in ambulatory managed COVID-19

24 Aug 2021

News & Updates

Filter by Specialty:

Specialty:

Colchicine: A potential outpatient treatment for PCR-confirmed COVID-19?

Colchicine: A potential outpatient treatment for PCR-confirmed COVID-19?

Omalizumab stops proliferation, transformation of fibrocytes in severe allergic asthma

Omalizumab stops proliferation, transformation of fibrocytes in severe allergic asthma

Delta and beyond: Is a third COVID-19 vaccine jab the answer?

Delta and beyond: Is a third COVID-19 vaccine jab the answer?

Zolpidem plus atomoxetine-oxybutynin improves sleep efficiency in OSA patients

Zolpidem plus atomoxetine-oxybutynin improves sleep efficiency in OSA patients

Airborne threat: Surgical masks may be the answer, but not cloth masks or face shields

Airborne threat: Surgical masks may be the answer, but not cloth masks or face shields

Studies highlight potential link between COVID-19 and cognitive impairment

Studies highlight potential link between COVID-19 and cognitive impairment

Keeping windows open best for preventing COVID-19 spread in cars

Keeping windows open best for preventing COVID-19 spread in cars

Leg, trunk mass decline in COPD patients

Leg, trunk mass decline in COPD patients

COVID-19 days fewer in children; experts explain why

COVID-19 days fewer in children; experts explain why

Adding azithromycin to standard care yields no survival benefit in ambulatory managed COVID-19

Adding azithromycin to standard care yields no survival benefit in ambulatory managed COVID-19